Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Ambea AB (publ)    AMBEA   SE0009663826

AMBEA AB (PUBL) (AMBEA)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Final bids due in sale of Finnish healthcare firm Mehiläinen

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/16/2018 | 05:05pm CEST

(LPC) - Private equity firms are expected to submit final bids this week for Finnish healthcare company Mehilainen, which is expected to fetch over €1.56bn (1.4 billion pounds), banking sources said on Wednesday.

(LPC) - Private equity firms are expected to submit final bids this week for Finnish healthcare company Mehilainen, which is expected to fetch over €1.56bn (1.4 billion pounds), banking sources said on Wednesday.

Carlyle, CVC and Nordic Capital are still in the running to buy the company, which is currently owned by Triton. Leveraged finance bankers are preparing financing based on an adjusted Ebitda figure of €120m.

An enterprise value of 13 to 15 times adjusted Ebitda would value the company at €1.56bn to €1.8bn, the sources said. Mehilainen reported underlying Ebitda of €92.8m for 2017, based on revenues of €755.5m.

The deal will add to a strong pipeline of European leveraged loans which includes buyout loans for other healthcare companies, such as an €880m equivalent first lien and €275m second lien financing for Zentiva, formerly Sanofi generics business.

Triton Capital carved Mehilainen out of parent company Ambea Group, following its initial €850m joint investment in Ambea with KKR in 2010.

Mehilainen merged with peer Mediverkko in February 2015, creating a group with 140 hospitals and care homes throughout Finland. Finnish pension funds Imarinen and Varma are co-owners of Mehilainen.

Carlyle, CVC and Nordic Capital declined to comment. Triton could not be reached for comment.

(Editing by Tessa Walsh)

By Max Bower

Stocks mentioned in the article
ChangeLast1st jan.
AMBEA AB (PUBL) 1.63% 74.9 Delayed Quote.1.56%
SANOFI 0.88% 73.3 Real-time Quote.2.02%
ZENTIVA SA --End-of-day quote.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AMBEA AB (PUBL)
08/14INVITATION : Presentation of Ambea’s second quarter report 2018
PU
08/14INVITATION : Presentation of Ambea's second quarter report 2018
AQ
06/26AMBEA PUBL : Vardaga and Skanska will build new nursing home in Helsingborg
AQ
06/12AMBEA PUBL : Changes in Investor Relations at Ambea
AQ
06/04AMBEA PUBL : Nytida acquires Tillväxthemmen
AQ
05/23AMBEA PUBL : Report from Ambea's Annual General Meeting 2018
AQ
05/17AMBEA PUBL : Quality Report for the first quarter 2018
PU
05/17AMBEA PUBL : interim report January-March 2018
AQ
05/17AMBEA PUBL : Quality Report for the first quarter 2018
AQ
05/16Final bids due in sale of Finnish healthcare firm Mehiläinen
RE
More news
Financials (SEK)
Sales 2018 6 037 M
EBIT 2018 444 M
Net income 2018 308 M
Debt 2018 2 056 M
Yield 2018 1,83%
P/E ratio 2018 16,21
P/E ratio 2019 13,83
EV / Sales 2018 1,14x
EV / Sales 2019 1,02x
Capitalization 4 840 M
Chart AMBEA AB (PUBL)
Duration : Period :
Ambea AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMBEA AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 78,5  SEK
Spread / Average Target 6,5%
EPS Revisions
Managers
NameTitle
Per Fredrik Gren President & Chief Executive Officer
Lena Hofsberger Chairman
Daniel Warnholtz Chief Financial Officer
Philip Bergquist Head-Information Technology, OPEX & Project Office
Patricia Briceño Rodriguez Director
Sector and Competitors
1st jan.Capitalization (M$)
AMBEA AB (PUBL)1.56%529
HCA HOLDINGS (HOSPITAL CORPORATION AMERICA)49.78%45 529
FRESENIUS MEDICAL CARE-3.14%29 970
LABORATORY CORPORATION OF AMERICA HOLDINGS14.22%18 565
QUEST DIAGNOSTICS11.22%15 230
DAVITA0.33%12 099